Evidence map›Paper›PMID 28395970›Full record

ArticleJournal of controlled release : official journal of the Controlled Release Society2017

Dynamic contrast enhanced MRI detects changes in vascular transport rate constants following treatment with thermally-sensitive liposomal doxorubicin.

Brett Z Fite, Azadeh Kheirolomoom, Josquin L Foiret, Jai W Seo, Lisa M Mahakian, Elizabeth S Ingham, Sarah M Tam, Alexander D Borowsky, Fitz-Roy E Curry, Katherine W Ferrara

Open access · greenAbstract read
In one paragraph

Article in Journal of controlled release : official journal of the Controlled Release Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Combining activatable nanodelivery with immunotherapy in a murine breast cancer model.Journal of controlled release : official journal of the Controlled Release Society · 2019
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Brett Z FiteDepartment of Biomedical Engineering, University of California, Davis, CA 95616, USA. Electronic address: bzfite@ucdavis.edu.
Azadeh KheirolomoomDepartment of Biomedical Engineering, University of California, Davis, CA 95616, USA. Electronic address: akheirolomoom@ucdavis.edu.
Josquin L FoiretDepartment of Biomedical Engineering, University of California, Davis, CA 95616, USA. Electronic address: jlfoiret@ucdavis.edu.
Jai W SeoDepartment of Biomedical Engineering, University of California, Davis, CA 95616, USA. Electronic address: jwseo@ucdavis.edu.
Lisa M MahakianDepartment of Biomedical Engineering, University of California, Davis, CA 95616, USA. Electronic address: lmmahakian@ucdavis.edu.
Elizabeth S InghamDepartment of Biomedical Engineering, University of California, Davis, CA 95616, USA. Electronic address: esingham@ucdavis.edu.
Sarah M TamDepartment of Biomedical Engineering, University of California, Davis, CA 95616, USA. Electronic address: smjohns@ucdavis.edu.
Alexander D BorowskyDepartment of Pathology and Laboratory Medicine, University of California, Davis, CA 95616, USA. Electronic address: adborowsky@ucdavis.edu.
Fitz-Roy E CurryDepartment of Physiology and Membrane Biology, University of California, Davis, CA 95616, USA. Electronic address: fecurry@ucdavis.edu.
Katherine W FerraraDepartment of Biomedical Engineering, University of California, Davis, CA 95616, USA. Electronic address: kwferrara@ucdavis.edu.
University of California System · USUniversity of California, Davis · US

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura Marcu · 2002 to 2026
$84.9M
Ultrasound Imaging and Local Drug Delivery in TumorsR01CA103828 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI FERRARA, KATHERINE W · 2004 to 2013
$10.4M
Specific and high-resolution ultrasound cancer imagingR01CA112356 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI FERRARA, KATHERINE W, FOIRET, JOSQUIN · 2005 to 2022
$6.1M
Ultrasound imaging and enhanced therapeutic responseR01CA134659 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FERRARA, KATHERINE W · 2009 to 2017
$4.4M
Image-guided ultrasound therapy and drug delivery in pancreatic cancerR01CA210553 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FERRARA, KATHERINE W · 2016 to 2020
$3.2M
Optimized ultrasound-enhanced immunotherapyR01CA199658 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FERRARA, KATHERINE W · 2015 to 2019
$2.5M
NCI NIH HHS P30 CA093373NCI NIH HHS R01 CA103828NCI NIH HHS R01 CA112356NCI NIH HHS R01 CA134659NCI NIH HHS R01 CA199658NCI NIH HHS R01 CA210553
6 · The paper itself

Abstract

Temperature-sensitive liposomal formulations of chemotherapeutics, such as doxorubicin, can achieve locally high drug concentrations within a tumor and tumor vasculature while maintaining low systemic toxicity. Further, doxorubicin delivery by temperature-sensitive liposomes can reliably cure local cancer in mouse models. Histological sections of treated tumors have detected red blood cell extravasation within tumors treated with temperature-sensitive doxorubicin and ultrasound hyperthermia. We hypothesize that the local release of drug into the tumor vasculature and resulting high drug concentration can alter vascular transport rate constants along with having direct tumoricidal effects. Dynamic contrast enhanced MRI (DCE-MRI) coupled with a pharmacokinetic model can detect and quantify changes in such vascular transport rate constants. Here, we set out to determine whether changes in rate constants resulting from intravascular drug release were detectable by MRI. We found that the accumulation of gadoteridol was enhanced in tumors treated with temperature-sensitive liposomal doxorubicin and ultrasound hyperthermia. While the initial uptake rate of the small molecule tracer was slower (k

Indexed as

Ultrasonic TherapyAnimalsAntibiotics, AntineoplasticBiological TransportCapillary PermeabilityContrast MediaDoxorubicinDrug LiberationFemaleGadoliniumMagnetic Resonance ImagingMice, NudeMicrobubblesNeoplasmsPolyethylene GlycolsAntibiotics, AntineoplasticContrast MediaDoxorubicinGadoliniumliposomal doxorubicinPolyethylene GlycolsDCE-MRIDoxorubicinHyperthermiaLiposomesVascular permeability

Identifiers

PMID28395970
PMCPMC5545100
OpenAlexW2604928737

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.